Biotechnology | FDA | Oncology | Therapeutics
Genentech drug Gazyva (obinutuzumab) was approved
On Nov. 13, 2013, Genentech announced that it’s drug Gazyva (obinutuzumab) was approved by the U.S. Food and…
-
-
Syntrix Biosystems won $115 million judgment in patent case against Illumina, the largest patent verdict in Washington state history
On Nov. 7, 2013 – Syntrix Biosystems announced a federal court in Tacoma, had granted the Auburn-based company…
-
Richard Scheller won Lasker Award
On Sept. 9, 2013 Genentech announced that Richard Scheller, Ph.D., Executive VP, Research and Early Development, was a…
-
Genome of the western painted turtle sequenced
On Apr. 3, 2013, scientists announced they had decoded the genome of the western painted turtle, one of…
-
Mountain pine beetle genome was decoded
On Mar. 27, 2013, researchers at the University of British Columbia and Canada’s Michael Smith Genome Sciences Centre,…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics
Genentech drug Kadcyla (ado-trastuzumab emtansine) was approved
On Feb. 22, 2013, the U.S. Food and Drug Administration (FDA) announced they had licensed ado-trastuzumab emtansine (Kadcyla)…
-
Amgen acquired deCODE Genetics for $415 million
On Dec. 12, 2012, deCODE genetics announced an agreement whereby Amgen acquired deCODE Genetics, a global leader in…
-
Lucentis approved for treatment of diabetic macular edema
On Aug. 10. 2012, Genentech announced that Lucentis (ranibizumab injection) was approved by the U.S. Food and Drug…
-
Roche announced the closure of the Nutley/Clifton campus
On Jun. 26, 2012, Roche announced it had closed the Nutley plant, established in 1929. The Nutley plant…
-
Biotechnology | Disease | FDA | Oncology | Therapeutics | Women's Health
Genentech drug Perjeta (pertuzumab) was approved
On Jun. 8, 2012, the U.S. Food and Drug Administration (FDA) announced that Genentech’s drug Perjeta (pertuzumab) was…
-
First patent application granted for CRISPR-Cas9 gene editing in all environments
On May 25, 2012, Drs. Jennifer Doudna, Emanulle Charpentier, Martin Jinek of UC Berkeley and Krzystof Chylinski of…
-
Hologic acquired Gen-Probe for $3.7 billion
On Apr. 30, 2012, Hologic announced the acquisition of San Diego-based Gen-Probe, a molecular diagnostics company, for $3.7…
-
The USDA confirmed detection of Bovine Spongiform Encephalopathy (BSE) in California
On Apr. 24, 2012, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
-
Single antibody shrinks variety of human tumors transplanted into mice, study showed
On Mar. 26, 2012, researchers at Stanford University School of Medicine reported study results that showed human tumors…
-
Biotechnology | FDA | Oncology | Therapeutics
The U.S. FDA approved Erivedge (vismodegib) capsule, the first medicine for adults with advanced basal cell carcinoma
On Jan. 30, 2012, the U.S. Food and Drug Administration (FDA) approved Genentech’s Erivedge (vismodegib) capsule, the first…
-
Revive & Restore was founded
In 2012, Ryan Phelan and Stewart Brand founded the Revive & Restore project within The Long Now Foundation,…
-
Biotechnology | Diagnostics | Disease | NIH | Non-Profit Research | Oncology | Therapeutics | Veterinary
The UC Davis Comprehensive Cancer Center received NCI designation
In 2012, The UC Davis Comprehensive Cancer Center received NCI comprehensive cancer designation. The center is a matrix…
-
CALIBR, the California Institute for Biomedical Research, was founded
In 2012, CALIBR, the California Institute for Biomedical Research (Calibr), was launched as a nonprofit translational research institute…
-
Renowned biochemist Michael A Marletta became president and CEO of The Scripps Research Institute
On Jan 1, 2012, renowned biochemist Michael A. Marletta became president and CEO of The Scripps Research Institute…
-
Genentech medicine approved for certain type of melanoma
On Aug. 17, 2011, Genentech announced that Elborafﾮ (vemurafenib) was approved by the FDA for the treatment of…
-
Stanford/Packard scientists found new uses for existing drugs by mining gene-activity data banks
On Aug. 17, 2011, researchers at the Stanford University School of Medicine announced they had paired up medicines…
-
Genentech drug Zelboraf (vemurafenib) was approved
On Aug. 16, 2011, the U.S. Food and Drug Administration (FDA) approved vemurafenib tablets (Zelboraf, Hoffmann-LaRoche Inc.) for…
-
TomoTherapy acquired by Accuray
On Jun. 13, 2011, Accuray announced it had completed its acquisition of TomoTherapy. The combination creates the premier…
-
The Priestley Medal was awarded to Ahmed H. Zewail
On Mar. 28, 2011, the Priestley Medal was awarded to Ahmed H. Zewail by the American Chemical Society…
-
J. Craig Venter Institute announced Single Virus Genomics
On Mar. 23, 2011, J. Craig Venter Institute researchers announced Single Virus Genomics, enabling the isolation and complete…
-
UCSF stem cell building was opened, a milestone for the pioneering program
On Feb. 9, 2011, the University of California, San Francisco (UCSF) celebrated the official opening of the Ray…
-
Stanford Medicine researchers used skin cells from patients with a severe genetic heart defect to create human heart cells with the same genetic mutation
On Feb. 9, 2011, Stanford researchers used skin cells from patients with a severe genetic heart defect to…
-
The Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research opened
On Oct. 29, 2010, The Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research…
-
US Supreme Court lifted a nationwide ban on cultivation of biotech alfalfa
On Jun. 21, 2010, the U.S. Supreme Court lifted a nationwide ban on cultivation of biotech alfalfa by…
-
The consolidated Dorris Neuroscience Center was dedicated at Scripps Research Institute
On May 25, 2010, the consolidated Dorris Neuroscience Center was dedicated at the Scripps Research Institute. The new…
